← Evidence library

BIB_360

ctDNA (Signatera) in Stage III melanoma neoadjuvant setting — mixed evidence; 2026 update.

Evidence grade

B

Tier

1 (peer-reviewed)

Cited by tasks

15, 17, 24

Identifiers

PMC12816504 · DOI:10.1177/17588359251412729

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_360/findings.md (research corpus). This page is a short context summary — not individualised medical advice.